The decanucleotide insertion/deletion polymorphism in the promoter region of the Ccagulation factor VII gene and the risk of familial myocardial infarction

Thrombosis Research

Volumn 98, Issue 1, 2000, Pages 9-17

  Di Castelnuovo, Augusto ^a   D'Orazio, Andria ^a   Amore, Concetta ^a   Falanga, Anna ^b   Donati, Maria Benedetta ^a   Iacoviello, Licia ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

Case control study; Factor VII levels; Factor VII polymorphisms; Myocardial infarction

Indexed keywords

BLOOD CLOTTING FACTOR 7;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DNA POLYMORPHISM; FAMILIAL DISEASE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; REGRESSION ANALYSIS; RISK ASSESSMENT;

AGED; ALLELES; FACTOR VII; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RISK; RISK FACTORS; SEQUENCE DELETION;

EID: 0033997379     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(99)00220-0     Document Type: Article

References (26)

1. Green F., Kelleher C., Wilkes H., Temple A., Meade T., Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb. 11:1991;540-546.
2. 353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study. Atherosclerosis. 119:1996;119-127.
3. Bernardi F., Arcieri P., Bertina R.M., Chiarotti F., Corral J., Pinotti M., Prydz H., Samama M., Sandset P.M., Strom R., Vicente Garcia V., Mariani G. Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between Northern and Southern European populations. Arterioscler Thromb Vasc Biol. 17:1997;2548-2553.
4. Iacoviello L., Di Castelnuovo A., De Knijff P., D'Orazio A., Amore C., Arboretti R., Kluft C., Donati M.B. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med. 338:1998;79-85.
5. Doggen C.J.M., Manger Cats V., Bertina R.M., Reitsma P.H., Vandenbroucke J.P., Rosendaal F.R. A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men. Thromb Haemost. 80:1998;281-285.
6. Corral J., Gonzalez-Conejero R., Lozano M.L., Rivera J., Vicente V. Genetic polymorphisms of factor VII are not associated with arterial thrombosis. Blood Coagul Fibrinolysis. 9:1998;267-272.
7. Marchetti G., Patracchini P., Papacchini M., Ferrati M., Bernardi F. A polymorphism in the 5′ region of coagulation factor VII gene (F7) caused by an inserted decanucleotide. Hum Genet. 90:1993;575-576.
8. de Knijff P., Green F., Johansen L.G., de Knijff P., Green F., Johansen L.G., Grootendorst D., Temple A., Cruickshank J.K., Humphries S.E., Jespersen J., Kluft C. New alleles in F7 VNTR. Hum Mol Genet. 3:1994;384.
9. Pollak E.S., Hung H.L., Godin W., Overton G.C., High K.A. Functional characterisation of the human factor VII 5′-flanking region. J Biol Chem. 271:1996;1738-1747.
10. Di Castelnuovo A., D'Orazio A., Amore C., Falanga A., Kluft C., Donati M.B., Iacoviello L. Genetic modulation of coagulation factor VII plasma levels. Contribution of different polymorphisms and gender-related effects Thromb Haemost. 80:1998;592-597.
11. Zoller B., Svensson P.J., He X., Dahlback B. Identification of the same factor V gene mutation in 47 out of 50 thrombosis-prone families with inherited resistance to activated protein C. J Clin Invest. 94:1994;2521-2524.
12. GISSI-2. A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction Lancet. 336:1990;65-71.
13. Roncaglioni M.C., Santoro L., D'Avanzo B., Negri E., Nobili A., Ledda A., Pietropaolo F., Franzosi M.G., Feruglio G.A., Maseri A. Role of family history in patients with myocardial infarction. An Italian case-control study Circulation. 85:1992;2065-2072.
14. Terwillinger J.D., Ott J. Handbook of human genetic linkage. 1994;The J. Hopkins University Press, London. p. 278-9.
15. Chiano M.N., Clayton D.G. Genotypic relative risk under ordered restriction. Genet Epidemiol. 15:1998;135-146.
16. Lundberg M., Fredlund P., Hallqvist J., Diderichsen F. A SAS program calculating three measures of interaction with confidence intervals. Epidemiology. 7:1996;655-656.
17. SAS Institute Inc., SAS/STAT Users Guide, Version 6. Cary, NC: SAS Institute Inc.; 1989.
18. Meade T.W., Mellows S., Brozovic M., Miller G.J., Chakrabarti R.R., North W.R.S., Haines A.P., Stirling Y., Imeson J.D., Thompson S.G. Haemostatic function and ischaemic heart disease. Principal results of the Northwick Park Heart Study Lancet. 2:1986;533-537.
19. Meade T.W., Ruddock V., Stirling Y., Chakrabarti R., Miller G.J. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet. 342:1993;1076-1079.
20. Heinrich J., Balleisen L., Schulte H., Assmann G., van de Loo J. Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb. 14:1994;54-59.
21. Thrombosis prevention trial. Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk Lancet. 351:1998;233-241.
22. Bernardi F., Marchetti G., Pinotti M., Arcieri P., Baroncini C., Papacchini M., Zepponi E., Ursicino N., Chiarotti F., Mariani G. Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol. 16:1996;72-76.
23. Sacchi E., Tagliabue L., Scoglio R., Baroncini C., Coppola R., Bernardi F., Mannucci P.M. Plasma factor VII levels are influenced by a polymorphism in the promoter region of the FVII gene. Blood Coagul Fibrinolysis. 7:1996;114-117.
24. de Maat M.P.M., Green F., de Knijff P., Jespersen J., Kluft C. Factor VII polymorphisms in populations with different risk of cardiovascular disease. Arterioscl Thromb Vasc Biol. 17:1997;1918-1923.
25. Papers from a workshop on Trends and determinants of coronary heart disease mortality: International comparisons, Bethesda, MD, USA, August 15-16, 1998. Int J Epidemiol 1989;18(Suppl 1):S1-230.
26. Hunault M., Arbini A.A., Lopaciuk S., Carew J.A., Bauer K.A. The Arg353Gln polymorphism reduces the level of coagulation factor VII. In vivo and in vitro studies. Arterioscler Thromb Vasc Biol. 17:1997;2825-2829.